Journal article · 2017

Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors

Andrea Astolfi, Tommaso Felicetti, Nunzio Iraci, Giuseppe Manfroni, Serena Massari, Donatella Pietrella, Oriana Tabarrini, Glenn William Kaatz, Maria Letizia Barreca, Stefano Sabatini, Violetta Cecchetti

Journal of Medicinal Chemistry, 60(4), 1598–1604 · Published 8 February 2017 · DOI 10.1021/acs.jmedchem.6b01439

View at the publisherCite this paper

In brief

“Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors” is a 2017 journal article by Andrea Astolfi and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 69 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
69
Most cited in
2020 (11)
Field-weighted impact
2.94
References
41
Authors
11

Abstract

An intriguing opportunity to address antimicrobial resistance is represented by the inhibition of efflux pumps. Focusing on NorA, the most important efflux pump of Staphylococcus aureus, an efflux pump inhibitors (EPIs) library was used for ligand-based pharmacophore modeling studies. By exploitation of the obtained models, an in silico drug repositioning approach allowed for the identification… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Astolfi, A., Felicetti, T., Iraci, N., Manfroni, G., Massari, S., Pietrella, D., Tabarrini, O., Kaatz, G. W., Barreca, M. L., Sabatini, S., & Cecchetti, V. (2017). Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors. Journal of Medicinal Chemistry, 60(4), 1598–1604. https://doi.org/10.1021/acs.jmedchem.6b01439

MLA 9

Astolfi, Andrea, et al. “Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.” Journal of Medicinal Chemistry, vol. 60, no. 4, 2017, pp. 1598–1604. https://doi.org/10.1021/acs.jmedchem.6b01439.

Chicago

Astolfi, Andrea, Tommaso Felicetti, Nunzio Iraci, Giuseppe Manfroni, Serena Massari, Donatella Pietrella, Oriana Tabarrini, et al. 2017. “Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.” Journal of Medicinal Chemistry 60 (4): 1598–1604. https://doi.org/10.1021/acs.jmedchem.6b01439.

Harvard

Astolfi, A. et al. (2017) ‘Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors’, Journal of Medicinal Chemistry, 60(4), pp. 1598–1604. doi:10.1021/acs.jmedchem.6b01439.

IEEE

A. Astolfi et al., “Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors,” Journal of Medicinal Chemistry, vol. 60, no. 4, pp. 1598–1604, 2017, doi: 10.1021/acs.jmedchem.6b01439.

BibTeX

@article{astolfi2017pharmacophore,
  title     = {{Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors}},
  author    = {Astolfi, Andrea and Felicetti, Tommaso and Iraci, Nunzio and Manfroni, Giuseppe and Massari, Serena and Pietrella, Donatella and Tabarrini, Oriana and Kaatz, Glenn William and Barreca, Maria Letizia and Sabatini, Stefano and Cecchetti, Violetta},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2017},
  volume    = {60},
  number    = {4},
  pages     = {1598--1604},
  doi       = {10.1021/acs.jmedchem.6b01439},
  url       = {https://doi.org/10.1021/acs.jmedchem.6b01439}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201722
201855
20191010
20201111
20211111
202277
20231111
202433
202566
202622

Its field-weighted citation impact is 2.94: it has been cited 2.94 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • NorA efflux pump
  • Staphylococcus aureus
  • efflux pump inhibitors
  • drug repurposing
  • pharmacophore modeling
  • antimicrobial resistance
  • approved drugs

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Astolfi, A., Felicetti, T., Iraci, N., Manfroni, G., Massari, S., Pietrella, D., Tabarrini, O., Kaatz, G. W., Barreca, M. L., Sabatini, S., & Cecchetti, V. (2017). Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors. Journal of Medicinal Chemistry, 60(4), 1598–1604. https://doi.org/10.1021/acs.jmedchem.6b01439

How many times has this paper been cited?

69 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Andrea Astolfi, Tommaso Felicetti, Nunzio Iraci, Giuseppe Manfroni, Serena Massari, Donatella Pietrella, Oriana Tabarrini, Glenn William Kaatz, Maria Letizia Barreca, Stefano Sabatini, Violetta Cecchetti.

What is the DOI of this paper?

10.1021/acs.jmedchem.6b01439, permanently at https://doi.org/10.1021/acs.jmedchem.6b01439. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.